Dense Breast Notification Laws Not Leading to More Screening Ultrasounds Dense Breast Notification Laws Not Leading to More Screening Ultrasounds
State laws requiring women with dense breasts to be told about the benefits of further imaging after mammography may not lead more women to get extra screening, a U.S. study suggests.Reuters Health Information
ConclusionsMRI is the best predictor of tumor size in breast cancer. Histologic type and tumor size are key parameters when estimating tumor size and should be taken into account when planning surgery. Patient age does not interfere with the interpretation of imaging tests.ResumenIntroducciónEl objetivo de este estudio fue evaluar qué prueba de imagen de las empleadas para medir el tamaño del cáncer de mama primario preoperatorio (mamografía, ecografía o resonancia magnética (RM)) se correlacionó mejor con el tamaño del tumor en la pieza quirúrgica posto...
Condition: Patient Experience, Satisfaction and Preference Intervention: Diagnostic Test: QT Scanner Sponsors: QT Ultrasound LLC; Analysis Group, Inc. Recruiting
We present in this article, a 42-year-old female patient with an invasive ductal carcinoma inside a phylloides tumor in the same breast.
State laws requiring women with dense breasts to be told about the benefits of further imaging after mammography may not lead more women to get extra screening, a U.S. study suggests.
Commercial activity surrounding radiology business intelligence software has...Read more on AuntMinnie.comRelated Reading: 3 reasons why growth in the mammography market will slow 4 key enterprise imaging takeaways from SIIM 2019 5 trends shaping the future of global ultrasound Advanced visualization and the cloud that never formed Is virtual reality in radiology becoming a reality?
Revenue in the global market for mammography systems is expected to slow in...Read more on AuntMinnie.comRelated Reading: 4 key enterprise imaging takeaways from SIIM 2019 5 trends shaping the future of global ultrasound Handheld ultrasound market poised for next wave of growth Video from ECR 2019: Steve Holloway on the exhibition hall 6 trends to watch at ECR 2019
Breast surgery patients go to a myriad of appointments unseen by the PACU staff. Nuclear Medicine, Mammography, Ultrasound, Seed Placement, Clip Placement, Imaging, Biopsies and consultative appointments all occur prior to being booked for surgery. In a time where the patient experience matters most, focus needs to be given to the patient population undergoing the most amount of pre-surgical, stressful appointments.
In this study, we have evaluated the accuracy of specimen mammogram (SM) with digital breast tomosynthesis (DBT) for margin assessment by comparing it to the excised margins as measured in final histopathology. This is a prospective observational study of patients with radiologically suspicious impalpable breast lesions. The patients underwent ultrasound-guided hook wire placement followed by excision of the lesion, subjected to digital tomosynthesis mammogram, and margins were revised on table when indicated. These findings were correlated with final histopathological margin. Our study included 30 patients and out of the ...
Conclusions: Fat-grafting sequelae may lead to early unplanned invasive and noninvasive procedures initiated by a variety of providers. In this study, fat grafting had no impact on local recurrence rate. As use of fat grafting grows, communication among breast cancer care providers and enhanced patient and caregiver education will be increasingly important in optimizing the multidisciplinary evaluation and monitoring of palpable breast lesions. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
Introduction: We investigated the downstream workup and costs associated with digital breast tomosynthesis (DBT) compared with 2-dimensional full field digital mammogram (FFDM) when employed as initial follow-up imaging in breast conservation therapy. Methods: Between the years 2015 and 2017, 450 consecutive breast conservation therapy patients, ages 32 to 89, with a follow-up DBT (n=162) or FFDM (n=288) were retrospectively reviewed. The primary endpoints were further workup after follow-up mammogram and associated health care costs at 1 year. A single DBT costs an estimated $149 compared with $111 for FFDM, based on...